Nanalysis Partners with IMRIS for Advanced MRI Technology Solutions

Nanalysis Partners with IMRIS: A New Era in MRI Technology

Nanalysis Scientific Corp., recognized as a leader in portable Nuclear Magnetic Resonance (NMR) instruments, has taken a significant step forward in the healthcare technology sector. On September 3, 2025, the company announced a partnership with IMRIS Imaging, Inc. to strengthen its Magnetic Resonance Imaging (MRI) capabilities. This five-year agreement marks a pivotal moment for both companies as they combine their expertise to develop innovative medical imaging solutions.

A Collaborative Pathway to Growth

Under this new licensing agreement, Nanalysis and IMRIS will engage in a multi-faceted collaboration that includes an upfront payment, providing immediate financial benefits alongside long-term growth potential. Sean Krakiwsky, CEO of Nanalysis, expressed pride in this collaboration, saying, "The non-exclusive agreement not only brings in cash flow immediately but also opens doors for larger revenue opportunities in the future. Our technologies are designed to complement one another, creating scalable growth globally."

Nanalysis has a robust portfolio that includes benchtop NMR and high-field NMR products, which are sold worldwide. The company has emphasized that the core electronics and software licensed to IMRIS are integral to these products, demonstrating how advances in MRI technology can synergize with their existing offerings.

Technology Integration and Strategic Alignment

Nanalysis CTO, Julien Muller, highlighted how their technology platform is designed for versatility across MRI, benchtop NMR, and high-field NMR applications. He noted that many core aspects of the physics and mathematics governing these technologies are the same, allowing for optimization and improved value across their product range. "Our strategy of using a unified technology platform validates our approach and prepares us for a future filled with potential," said Muller.

Partnership with IMRIS aligns with Nanalysis's vision of developing a robust MRI solution that addresses the urgent needs of patients, clinicians, and hospitals. IMRIS’s capabilities in intraoperative MRI—where imaging is integrated directly into operating rooms—are particularly transformative. This technology not only supports timely decisions during surgical procedures but also enhances overall patient care.

IMRIS: A Leader in Image-Guided Solutions

IMRIS Imaging is renowned for its innovative solutions in the field of image guidance for surgery, offering fully integrated systems that improve the workflow within operating rooms. Marc Buntaine, the CEO at IMRIS, spoke highly of Nanalysis, stating, "The rigorous vetting process for critical components left us impressed with Julien and the Nanalysis team. We believe that their MRI console is key to our success, and we are looking forward to our future projects together."

IMRIS has a successful track record, with over 70,000 patients benefiting from its technologies that enhance surgical outcomes. This partnership could further expand the reach of both companies, making high-quality MRI services more accessible in various clinical settings.

Future Horizons

The collaboration between Nanalysis and IMRIS is expected to accelerate the development and commercialization of advanced MRI technologies while enhancing the operational effectiveness of both companies. The fusion of their respective technologies could lead to greater innovation and an improved standard of care within theaters across medical facilities.

As the healthcare landscape continues to evolve, partnerships like this one are essential for driving advancements in medical technology. By combining their strengths, Nanalysis and IMRIS are setting the stage for a future marked by significant progress in imaging solutions.

This successful licensing agreement not only strengthens both firms but also promises to enhance patient care through improved imaging capabilities and operational efficiencies in the surgical environment. The next five years will be crucial as these two organizations work toward transforming the future of MRI technology together.